GFM-Acadesine: A Phase I-II Trial of Acadesine
NCT01813838
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Renal toxicity
Conditions
SMD
Interventions
DRUG:
ACADESINE 140mg/kg/d
DRUG:
ACADESINE 210mg/kg/d
DRUG:
ACADESINE 315mg/kg/d
Sponsor
Groupe Francophone des Myelodysplasies
Collaborators
[object Object]